Effect of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury

64Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have studied the effects of bolus doses of midazolam 0.15 mg kg-1 i.v. on intracranial pressure (ICP), mean arterial pressure (MAP) and cerebral perfusion pressure (CPP) in 12 patients with severe head injury (Glasgow Coma Scale score ≤6). The study was performed in patients aged 17-44 yr who were sedated (phenoperidine 20 μg kg-1 h-1) and paralysed (vecuronium 2 mg h-1). Midazolam reduced MAP from 89.0 mm Hg to 75.0 mm Hg (P<0.0001), while CPP decreased from 71.0 mm Hg to 55.8 mm Hg (P<0.0001). During the study, CPP decreased to less than 50 mm Hg in four patients. Midazolam induced small, non-significant changes in ICP. However, when control ICP was less than 18 mm Hg (n=7 patients), an increase in ICP was observed. The remaining five patients (control ICP ≥18 mm Hg) exhibited a slight decrease in ICP. These findings suggest that bolus administration of midazolam should be performed with great caution in patients with severe head injury, especially when ICP is less than 18 mm Hg. © 1993 British Journal of Anaesthesia.

Cite

CITATION STYLE

APA

Papazian, L., Albanese, J., Thirion, X., Perrin, G., Durbec, O., & Martin, C. (1993). Effect of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury. British Journal of Anaesthesia, 71(2), 267–271. https://doi.org/10.1093/bja/71.2.267

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free